Results 141 to 150 of about 1,112,952 (328)
Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating Scale
ABSTRACT The placebo response in clinical trials in ataxias complicates outcome interpretation and potentially obscures genuine treatment effects. We analyzed placebo group data from past trials in Friedreich Ataxia and observed notable responses in appendicular items, in contrast to minimal changes in axial function, as measured by respective ...
Christian Rummey +2 more
wiley +1 more source
Adaptive Online Module Prototype for Learning Unified Modelling Language (UML)
Arief Hidayat, Victor Gayuh Utomo
openalex +3 more sources
QSVD: Efficient Low-rank Approximation for Unified Query-Key-Value Weight Compression in Low-Precision Vision-Language Models [PDF]
Yutong Wang, Haiyu Wang, Sai Qian Zhang
openalex +1 more source
Multi‐Omics Integration for Advancing Glioma Precision Medicine
ABSTRACT Gliomas are among the most malignant and aggressive tumors of the central nervous system, characterized by the absence of early diagnostic markers, poor prognosis, and a lack of effective treatments. Advances in high‐throughput technologies have facilitated a refined molecular classification of gliomas, incorporating genetic features. However,
Maria Guarnaccia +4 more
wiley +1 more source
Object-oriented modelling with unified modelling language 2.0 for simple software application based on agile methodology [PDF]
Harco Leslie Hendric Spits Warnars
openalex +1 more source
Foundations of the Unified Modeling Language. [PDF]
Object-oriented analysis and design is an increasingly popular software development method. The Unified Modeling Language (UML) has recently been proposed as a standard language for expressing object-oriented designs. Unfor- tunately, in its present form
Clark, Anthony, Evans, Andy
core
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein +7 more
wiley +1 more source
Bridging Large Language Models and Optimization: A Unified Framework for Text-attributed Combinatorial Optimization [PDF]
Xia Jiang +3 more
openalex +1 more source

